At OncoOne,
we are committed to building a strong portfolio of life-changing next-generation radiotherapeutics through our proprietary PreTarg-it® platform. Our goal is to transform outcomes for patients affected by cancers.
We seek partners
who share our dedication and bring complementary expertise to expand our capabilities through innovation and collaboration.
Our pipeline
is currently at the preclinical stage, with programs designed for partnering and clinical translation. We serve as a trusted and flexible partner for collaboration, co-development, and licensing - turning early scientific insights into tangible clinical progress.
At OncoOne, we are committed to building a strong portfolio of life-changing next-generation radiotherapeutics through our proprietary PreTarg-it® platform. Our goal is to transform outcomes for patients affected by cancers.
We seek partners who share our dedication and bring complementary expertise to expand our capabilities through innovation and collaboration.
Our pipeline is currently at the preclinical stage, with programs designed for partnering and clinical translation. We serve as a trusted and flexible partner for collaboration, co-development, and licensing - turning early scientific insights into tangible clinical progress.
Interested in Shaping the Future of Radioimmunotherapy?
OncoOne is seeking strategic partners to advance its PreTarg-it® pipeline through:
Accelerated clinical development of selected programs
Access to partner expertise in specific disease areas and drug development
Have We Piqued Your Interest?
Get in touch
Labs and Offices
OncoOne Research & Development GmbH
Karl-Farkas-Gasse 22
1030 Vienna, Austria
